What question did this study set out to answer?

The study aims to characterize the genetic landscape of angiosarcoma cell lines to identify novel molecular targets.

Comprehensive Genomic Profiling Unveils RAS Pathway Activation in Angiosarcoma Cells

View Full Paper

Ask AI

Bookmark

Authors

Genomic profiling uncovers RAS pathway activation in angiosarcoma, suggesting new therapeutic targets.

The study aims to characterize the genetic landscape of angiosarcoma cell lines to identify novel molecular targets.
Established genomic profiles using Whole Exome Sequencing and Oxford Nanopore sequencing.
Analyzed a panel of angiosarcoma cell lines for single nucleotide variants (SNVs) and copy number variations (CNV).
Conducted anti-cancer drug screening with RAS inhibitor RMC-7977.
Identified alterations in CDK2A, PTPRB, and RAS in angiosarcoma cell lines.
RMC-7977 effectively suppressed cell growth in both RAS-mutated and wild-type cells.
Widespread activation of the RAS signaling pathway observed in primary angiosarcoma patient tissues.

Lee et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark